ACT Biotech, Inc
Quick facts
Phase 2 pipeline
- Cisplatin, Capecitabine, Telatinib · Oncology
Cisplatin works by crosslinking DNA, thereby inhibiting DNA replication and transcription, while Capecitabine is a prodrug that is converted into 5-fluorouracil, which inhibits thymidylate synthase, and Telatinib is a tyrosine kinase inhibitor that targets the VEGFR and PDGFR pathways.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Related
- Sector hub: All tracked pharma companies